SCHEMBL7672835

SCHEMBL7672835

COC(=O)c1cc(C#N)c(Br)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 7/20 0.46
KDM4E B2RXH2 6/20 0.46
HPGD P15428 4/20 0.46
CRHBP P24387 2/20 0.46
CRHR2 Q13324 2/20 0.46
GAA P10253 2/20 0.46
TDP1 Q9NUW8 1/20 0.44
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
BRD4 O60885 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
NR4A2 P43354 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676590 0.84 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL7666116 0.80 KDM4E (0.49) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL7667101 0.79 KDM4E (0.43) SMN1; SMN2ALDH1A1KDM4EHPGDGAA
SCHEMBL5750855 0.78 IMPDH2 (0.53) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL9090897 0.77 KDM4E (0.55) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL31287979 0.75 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL4825804 0.75 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL2647337 0.75 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL23043990 0.74 GAA (0.53) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP
SCHEMBL181067 0.74 ALDH1A1 (0.55) SMN1; SMN2ALDH1A1KDM4EHPGDCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed